The article critiques the "vitamin vs. painkiller" metaphor in startup advice, emphasizing that founders rarely intend to create a non-essential product. Instead, the author offers concrete tests to help founders determine if their product is genuinely necessary for buyers. This guidance targets B2B founders, particularly those struggling with product-market fit and early sales. One key point is understanding a product's place in a buyer's budget, especially during economic downturns. The author suggests that founders should aim to be among the last products cut from a budget reduction spreadsheet. Products like essential infrastructure, communication tools, and systems of record tend to be prioritized. If a founder can't envision their product in that top tier, it's likely a "vitamin." The article also highlights two critical signals from potential users: strong negative feedback indicating a contrarian idea and enthusiastic interest from someone willing to pay. The latter indicates a real problem that people want solved, essential for validating a product concept. The author warns against chasing problems that users don’t prioritize solving, often seen in early-stage tech or compliance areas. Lastly, the notion of being "10x better" is reframed as needing to excel in a specific area for a specific audience. This clarity helps avoid unnecessary competition and aligns product benefits with user needs.